Reiko Arita1, Naoyuki Morishige2, Shizuka Koh3, Rika Shirakawa4, Motoko Kawashima5, Tohru Sakimoto6, Takashi Suzuki7, Kazuo Tsubota8. 1. Lid and Meibomian Gland Working Group, Japan; Department of Ophthalmology, Itoh Clinic, Saitama, Japan; Department of Ophthalmology, University of Tokyo, Tokyo, Japan; Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan. Electronic address: ritoh@za2.so-net.ne.jp. 2. Lid and Meibomian Gland Working Group, Japan; Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan. 3. Lid and Meibomian Gland Working Group, Japan; Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan. 4. Lid and Meibomian Gland Working Group, Japan; Department of Ophthalmology, University of Tokyo, Tokyo, Japan. 5. Lid and Meibomian Gland Working Group, Japan; Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan. 6. Lid and Meibomian Gland Working Group, Japan; Department of Ophthalmology, Nihon University School of Medicine, Tokyo, Japan. 7. Lid and Meibomian Gland Working Group, Japan; Department of Ophthalmology, Ehime University Graduate School of Medicine, Ehime, Japan. 8. Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.
Abstract
PURPOSE: To compare tear film parameters as well as meibomian gland morphologic features and function among patients with meibomian gland dysfunction (MGD), those with non-Sjögren syndrome aqueous-deficient dry eye (non-SS ADDE), those with non-SS ADDE and MGD, and normal subjects. DESIGN: Multicenter, cross-sectional, observational case series. PARTICIPANTS: Forty-one eyes of 41 patients (all women; mean age ± standard deviation, 62.1±9.9 years) with non-SS ADDE, 70 eyes of 70 patients (all women; 66.0±8.7 years) with MGD, 17 eyes of 17 patients (all women; 72.4±7.8 years) with non-SS ADDE and MGD, and 70 eyes of 70 normal control subjects (all women; 65.0±7.1 years). METHODS: Ocular symptoms were scored from 0 to 14 and lid margin abnormalities from 0 to 4 according to their respective number. Meibomian gland changes were scored from 0 to 6 (meiboscore) on the basis of noncontact meibography findings, and meibum was graded from 0 to 3 depending on its volume and quality. Conjunctival and corneal epithelial damage were scored from 0 to 9 (fluorescein score). Tear film break-up time (TBUT) was measured as an index of tear film stability, and tear fluid production was evaluated with Schirmer's test. MAIN OUTCOME MEASURES: Ocular symptom score, lid margin abnormality score, meiboscore, meibum grade, fluorescein score, TBUT, and Schirmer's test value. RESULTS: The ocular symptom score did not differ significantly between the MGD and non-SS ADDE groups (P = 0.762). The lid margin abnormality score, meiboscore, and meibum grade were significantly higher in the MGD group than in the non-SS ADDE group (P = 0.0012, P < 0.0001, and P < 0.0001, respectively). The fluorescein score, TBUT, and Schirmer's test value were significantly worse in the non-SS ADDE group than in the MGD group (P < 0.0001, P = 0.0061, and P < 0.0001, respectively). The meiboscore correlated significantly with Schirmer's test value only in the MGD group (ρ = 0.508, P = 8.3×10(-6)). CONCLUSIONS: An increase in tear fluid production likely compensates for loss of meibomian glands in individuals with MGD.
PURPOSE: To compare tear film parameters as well as meibomian gland morphologic features and function among patients with meibomian gland dysfunction (MGD), those with non-Sjögren syndrome aqueous-deficient dry eye (non-SS ADDE), those with non-SS ADDE and MGD, and normal subjects. DESIGN: Multicenter, cross-sectional, observational case series. PARTICIPANTS: Forty-one eyes of 41 patients (all women; mean age ± standard deviation, 62.1±9.9 years) with non-SS ADDE, 70 eyes of 70 patients (all women; 66.0±8.7 years) with MGD, 17 eyes of 17 patients (all women; 72.4±7.8 years) with non-SS ADDE and MGD, and 70 eyes of 70 normal control subjects (all women; 65.0±7.1 years). METHODS: Ocular symptoms were scored from 0 to 14 and lid margin abnormalities from 0 to 4 according to their respective number. Meibomian gland changes were scored from 0 to 6 (meiboscore) on the basis of noncontact meibography findings, and meibum was graded from 0 to 3 depending on its volume and quality. Conjunctival and corneal epithelial damage were scored from 0 to 9 (fluorescein score). Tear film break-up time (TBUT) was measured as an index of tear film stability, and tear fluid production was evaluated with Schirmer's test. MAIN OUTCOME MEASURES: Ocular symptom score, lid margin abnormality score, meiboscore, meibum grade, fluorescein score, TBUT, and Schirmer's test value. RESULTS: The ocular symptom score did not differ significantly between the MGD and non-SS ADDE groups (P = 0.762). The lid margin abnormality score, meiboscore, and meibum grade were significantly higher in the MGD group than in the non-SS ADDE group (P = 0.0012, P < 0.0001, and P < 0.0001, respectively). The fluorescein score, TBUT, and Schirmer's test value were significantly worse in the non-SS ADDE group than in the MGD group (P < 0.0001, P = 0.0061, and P < 0.0001, respectively). The meiboscore correlated significantly with Schirmer's test value only in the MGD group (ρ = 0.508, P = 8.3×10(-6)). CONCLUSIONS: An increase in tear fluid production likely compensates for loss of meibomian glands in individuals with MGD.
Authors: Brian C Leonard; Kathleen A Stewart; Gillian C Shaw; Alyssa L Hoehn; Amelia A Stanley; Christopher J Murphy; Sara M Thomasy Journal: Cornea Date: 2019-12 Impact factor: 2.651
Authors: Dongfang Yu; Yogesh Saini; Gang Chen; Andrew J Ghio; Hong Dang; Kimberlie A Burns; Yang Wang; Richard M Davis; Scott H Randell; Charles R Esther; Friedrich Paulsen; Richard C Boucher Journal: Am J Pathol Date: 2017-10-26 Impact factor: 4.307
Authors: Min Kyu Yang; Ho-Seok Sa; Namju Kim; Hyun Sun Jeon; Joon Young Hyon; Hokyung Choung; Sang In Khwarg Journal: PLoS One Date: 2022-04-14 Impact factor: 3.752
Authors: Arthur S Polans; Jonathan F McAnulty; Paul O Phelps; Soesiawati R Darjatmoko; Christopher K Burris; Daniel M Albert Journal: Ocul Oncol Pathol Date: 2017-07-19